4A1i 01-4A1 05-2018 (interpretive)


4A1i 01-4A1 05-2018 (interpretive) - Rackcdn.comhttps://75c17d9f6eecafb09b78-695e1a25d6559f5c6a6714b54be309d0.ssl.cf3.rackcdn.c...

2 downloads 218 Views 114KB Size

UK NEQAS FOR H&I SCHEME 4A1i - Interpretive HLA Genotype ASSESSMENT TYPING RESULTS OF SAMPLE 4A1i 01/2018 DESPATCHED ON 17TH APRIL 2018 HLA-

Result Summary Number Unacceptable Number NT Lab No. 6 9 11 12 14 15 20 23 24 26 28 38 39 41 42 45 48 51 54 58 62 112 128 130 133 141 142 156 195 206 207 209 220 227 245 260 268 292 294 323

A YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES

Assessment HLAB Bw4/6 Cw DR DRB51/52/53 YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES

DQ YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES

A A3 A2

A A24 Blank

B B7

B B7/Blank B44

Bw4/6 Bw6 Bw4

Cw Cw7

Cw Cw7/Blank 5

DR DR15

A 4 0

A 4 0

B 3 0

B 4 0

Bw4/6 5 0

Cw 2 0

Cw 3 0

DR 3 0

A 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3

A 24 24 24(9) 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24

B 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7

B

Bw 6 6 6 6 6 6 6 6 6

Cw 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7

Cw

3

24

7

3

24(9)

7

2 3 3 3 3 3 3 3 3 3 3 3 3 3

24 24 24 24 24 24 24 24 24(9) 24 24 24 24

7 7 7 7 7 7 7 7 7 7 7 7 7 7

7

44(12)

7

7

6 6 6 6 6 6 6 6 6 6 6

7

HLADR 15 15 15(2) 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15

DR DR51/52/53 DR15/Blank DR51 DR 3 0

DRB51/52/53 DRB51/52/53 3 3 0 0

DR

DR51 51 51 51 51 51 51 51 51 51

15

51 51 51 51 51 51 51 51 51 51 51

15

DR51/52/53 -

DR53

DQ DQ6 DQ 3 0

DQ 4 0

DQ 6 6 6(1) 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6

DQ

7

15

6

6

7

15(2)

6(1)

4, 6

7 7 7 7 7 7 7 7 7 7 7 7 7 7

4, 6 6 6 6 6 4, 6 4, 6 6 6 6 6 6

5

7

7

15(2) 15 15 15 15 15 15 15 15 15(2) 15 15 15 15

7

15

15

51 51 51 51 51 51 51 51 51 51 51 51 51

53

DQ DQ6/Blank Acceptable 2 Unacceptable

6(1) 6 6 6 6 6 6 6 6 6(1) 6 6 6 6

Comments

6

6

2

6

6

Samples with results that are deemed ‘unacceptable’ for Scheme 4A1 will not be assessed in Scheme 4A1i

UK NEQAS for H&I is operated by Velindre NHS Trust, a UKAS proficiency testing provider No 8351. © Confidential report; no data may be published without permission from UK NEQAS for H&I

NEQ-137 Issue 1 Effective Date 06/02/17 P. 1 of 5

UK NEQAS FOR H&I SCHEME 4A1i - Interpretive HLA Genotype ASSESSMENT TYPING RESULTS OF SAMPLE 4A1i 02/2018 DESPATCHED ON 17TH APRIL 2018 HLA-

Result Summary Number Unacceptable Number NT Lab No. 6 9 11 12 14 15 20 23 24 26 28 38 39 41 42 45 48 51 54 58 62 112 128 130 133 141 142 156 195 206 207 209 220 227 245 260 268 292 294 323

A YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES

Assessment HLAB Bw4/6 Cw DR DRB51/52/53 YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES

DQ YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES

A A2 A3

A A2/Blank A24

B B7

A 4 0

A 4 0

B 3 0

B 4 0

Bw4/6 5 0

A 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2

A

B 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7

B 44 44 44(12) 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44

Bw 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6

2

7

44

2

7

44(12)

7 7 7 7 7 7 7 7 7 7 7 7 7 7

44 44 44 44 44 44 44 44 44(12) 44 44 44 44

3 2 2 2 2 2 2 2 2 2 2 2 2 2

2

24(9)

2

B Bw4/6 Cw B44 Bw4/6 Cw5 B7/Blank Cw7/Blank

4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6

4, 6

Cw Cw7

DR DR7

DR DR15

Cw 2 0

Cw 3 0

DR 3 0

DR 3 0

Cw 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5

Cw 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7

HLADR 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7

5

7

7

5

7

5 5 5 5 5 5 5 5 5 5 5 5 5

7 7 7 7 7 7 7 7 7 7 7 7 7 7

6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6

DQ DQ2

DQ DQ6 DQ8

DQ 3 0

DQ 4 0

DQ 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2

DQ 6 6 6(1) 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6

15

2

6

7

15(2)

2

6(1)

7 7 7 7 7 7 7 7 7 7 7 7 7

15(2) 15 15 15 15 15 15 15 15 15(2) 15 15 15 15

2 2 2 2 2 2 2 2 2 2 2 2 2

6(1) 6 6 6 6 6 6 6 6 1, 8(1), NULL 6 6 6 6

DR 15 15 15(2) 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15

DR51/52/53 DR51

DR51/52/53 DR53

DRB51/52/53 DRB51/52/53 3 3 0 0 DR51 51 51 51 51 51 51 51 51 51

DR53 53 53 53 53 53 53 53 53 53

51 51 51 51 51 51 51 51 51 51 51

53 53 53 53 53 53 53 53 53 53 53

51 51 51 51 51 51 51 51 51 51 51 51 51

53 53 53 53 53 53 53 53 53 53 53 53

Samples with results that are deemed ‘unacceptable’ for Scheme 4A1 will not be assessed in Scheme 4A1i

UK NEQAS for H&I is operated by Velindre NHS Trust, a UKAS proficiency testing provider No 8351. © Confidential report; no data may be published without permission from UK NEQAS for H&I

Acceptable Unacceptable

Comments

NEQ-137 Issue 1 Effective Date 06/02/17 P. 2 of 5

UK NEQAS FOR H&I SCHEME 4A1i - Interpretive HLA Genotype ASSESSMENT TYPING RESULTS OF SAMPLE 4A1i 03/2018 DESPATCHED ON 17TH APRIL 2018 HLA-

Result Summary Number Unacceptable Number NT Lab No. 6 9 11 12 14 15 20 23 24 26 28 38 39 41 42 45 48 51 54 58 62 112 128 130 133 141 142 156 195 206 207 209 220 227 245 260 268 292 294 323

A YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES

Assessment HLAB Bw4/6 Cw DR DRB51/52/53 YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES

A A2

A A29

B B45

B B51

Bw4/6 Bw4/6

Cw Cw4 Cw5

Cw Cw6 Cw7

DR DR8

DR DR17

A 3 1

A 3 1

B 3 1

B 3 1

Bw4/6 3 1

Cw 3 1

Cw 3 1

DR 3 1

DR 3 1

A 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 NT 2 2 2 2 2

A 29 29 29(19) 29 29 29 29 29 29 29 29 29 29 29 29 NT 29 29 29 29 29

B 45 45 45(12) 45 45 45 45 45 45 45 45 45 45 45 45 NT 45 45 45 45 45

B 51 51 51(5) 51 51 51 51 51 51 51 51 51 51 51 51 NT 51 51 51 51 51

Bw 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6

Cw 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 NT 4 5 4 4 4

Cw 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 NT 6 7 6 6 6

DR 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 NT 8 8 8 8 8

DR 17 17 17(3) 17 17 17 17 17 17 17 17 17 17 17 17 NT 17 17 17 17 17

2

29

45

51

4

6

8

17

2

29(19)

45(12)

51(5)

4, 6

4

6

8

17(3)

2 2 2 2 2 2 2 2 2 2 2 2 2 2

29(19) 29 29 29 29 29 29 29 29 29(19) 29 29 29 29

45(12) 45 45 45 45 45 45 45 45 45(12) 45 45 45 45

51(5) 51 51 51 51 51 51 51 51 51(5) 51 51 51 51

4, 6

4 4 4 4 4 4 4 4 4 4 4 4 4 4

6 6 6 6 6 6 6 6 6 6 6 6 6 6

8 8 8 8 8 8 8 8 8 8 8 8 8 8

17(3) 17 17 17 17 17 17 17 17 17(3) 17 17 17 17

DR51/52/53 DR52

DQ DQ2

DQ DQ4

Acceptable Unacceptable

DRB51/52/53 DRB51/52/53 DRB51/52/53 3 3 3 1 1 1

HLADQ YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES

4, 6 4, 6 4, 6 4, 6 4, 6 NT 4, 6 4, 6 4, 6 4, 6 4, 6

4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6

DR52 52 52 52 52 52 52 52 52 52 52 52 52 52 52 NT 52 52 52 52 52

DQB1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 NT 2 2 2 2 2

DQB1 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 NT 4 4 4 4 4

Comments

4

52 52 52 52 52 52 52 52 52 52 52 52 52

2

4

2 2 2 2 2 2 2 2 2 2 2 2 2 2

4 4 4 4 4 4 4 4 4 4 4 4 4 4

Samples with results that are deemed ‘unacceptable’ for Scheme 4A1 will not be assessed in Scheme 4A1i.

UK NEQAS for H&I is operated by Velindre NHS Trust, a UKAS proficiency testing provider No 8351. © Confidential report; no data may be published without permission from UK NEQAS for H&I

NEQ-137 Issue 1 Effective Date 06/02/17 P. 3 of 5

UK NEQAS FOR H&I SCHEME 4A1i - Interpretive HLA Genotype ASSESSMENT TYPING RESULTS OF SAMPLE 4A1i 04/2018 DESPATCHED ON 17TH APRIL 2018 HLA-

Result Summary Number Unacceptable Number NT Lab No.

A

B

6 9 11 12 14 15 20 23 24 26 28 38 39 41 42 45 48 51 54 58 62 112 128 130 133 141 142 156 195 206 207 209 220 227 245 260 268 292 294 323

YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES

YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES

Assessment HLABw4/6 Cw DR DRB51/52/53 YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES

YES YES YES YES YES YES YES YES YES

YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES

YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES

YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES

YES YES YES YES YES YES YES YES YES YES YES YES

YES YES YES YES YES YES YES YES

A A2

A A11

B B13

B B60

Bw4/6 Bw4/6

Cw Cw6

Cw Cw10 Cw3

DR DR4

DR DR13

DR51/52/53 DR52

A 3 0

A 3 0

B 3 0

B 3 0

Bw4/6 3 0

Cw 2 0

Cw 4 0

DR 3 0

DR 3 0

A

A

B

B

Bw

Cw

Cw

DR

DR

DR52

2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2

11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11

13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13

60 60 60(40) 60 60 60 60 60 60 60 60 60 60 60 60 60 60 60 60 60 60

4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6

6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6

10 10 10(3) 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 3

4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4

13 13 13(6) 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13

2

11

13

60

6

10

4

2

11

13

60(40)

4, 6

6

10(3)

2 2 2 2 2 2 2 2 2 2 2 2 2 2

11 11 11 11 11 11 11 11 11 11 11 11 11 11

13 13 13 13 13 13 13 13 13 13 13 13 13 13

60(40) 60 60 60 60 60 60 60 60 60(40) 60 60 60 60

4, 6

6 6 6 6 6 6 6 6 6 6 6 6 6 6

10(3) 10 10 10 3 10 10 10 10 10(3) 10 10 10 10

DR51/52/53 DR53

DQ DQ6

DQ DQ8

DQ 3 0

DQ 3 0

DR53

DQ

DQ

52 52 52 52 52 52 52 52 52

53 53 53 53 53 53 53 53 53

52 52 52 52 52 52 52 52 52 52 52

53 53 53 53 53 53 53 53 53 53 53

6 6 6(1) 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6

8 8 8(3) 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8

13

6

8

4

13(6)

6(1)

8(3)

4 4 4 4 4 4 4 4 4 4 4 4 4 4

13(6) 13 13 13 13 13 13 13 13 13(6) 13 13 13 13

6 6 6 6 6 6 6 6 6 6(1) 6 6 6 6

8(3) 8 8 8 8 8 8 8 8 8(3) 8 8 8 8

DRB51/52/53 DRB51/52/53 3 3 0 0

Acceptable Unacceptable

HLADQ YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES

4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6

4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6 4, 6

52

53

52 52 52 52 52 52 52 52 52 52 52 52

53 53 53 53 53 53 53 53 53 53 53 53

Samples with results that are deemed ‘unacceptable’ for Scheme 4A1 will not be assessed in Scheme 4A1i

UK NEQAS for H&I is operated by Velindre NHS Trust, a UKAS proficiency testing provider No 8351. © Confidential report; no data may be published without permission from UK NEQAS for H&I

Comments

NEQ-137 Issue 1 Effective Date 06/02/17 P. 4 of 5

UK NEQAS FOR H&I SCHEME 4A1i - Interpretive HLA Genotype ASSESSMENT TYPING RESULTS OF SAMPLE 4A1i 05/2018 DESPATCHED ON 17TH APRIL 2018 HLA-

Result Summary Number Unacceptable Number NT Lab No. 6 9 11 12 14 15 20 23 24 26 28 38 39 41 42 45 48 51 54 58 62 112 128 130 133 141 142 156 195 206 207 209 220 227 245 260 268 292 294 323

A YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES

Assessment HLAB Bw4/6 Cw DR DRB51/52/53 YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES

DQ YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES

A A2

A A25

B B44

B B58

Bw4/6 Bw4

Cw Cw7

Cw Cw-

DR DR13

DR DR13/Blank

DR51/52/53 DR52

DQ DQ6

DQ DQ7

A 3 0

A 3 0

B 3 0

B 3 0

Bw4/6 3 0

Cw 2 0

Cw 2 0

DR 3 0

DR 3 0

DRB51/52/53 4 0

DQ 3 0

DQ 3 0

A 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2

A 25 25 25(10) 25 25 25 25 25 25 25 25 25 25 25 25 25 25 25 25 25 25

B 44 44 44(12) 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44

B 58 58 58(17) 58 58 58 58 58 58 58 58 58 58 58 58 58 58 58 58 58 58

Bw 4 4 4 4 4 4 4 4 4

Cw 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7

DR 13 13 13(6) 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13

DR 13

DR52 52 52 52 52 52 52 52 52 52

DQ 6 6 6(1) 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6

DQ 7 7 7(3) 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7

2

25

44

58

2

25(10)

44(12)

58(17)

2 2 2 2 2 2 2 2 2 2 2 2 2 2

25(10) 25 25 25 25 25 25 25 25 25(10) 25 25 25 25

44(12) 44 44 44 44 44 44 44 44 44(12) 44 44 44 44

58(17) 58 58 58 58 55 58 58 58 58(17) 58 58 58 58

4 4 4 4 4 4 4 4 4 4 4

HLACw 7

7

7 7 7 7 7 7

7

13

13 13 13 13 13 13

13

52 52 52 52 52 52 52 52 52 52 52

7

13

6

7

4

7

13(6)

6(1)

7(3)

4

7 7 7 7 7 7 7 7 7 7 7 7 7 7

13(6) 13 13 13 13 13 13 13 13 13(6) 13 13 13 13

6 6 6 6 6 6 6 6 6 6(1) 6 6 6 6

7(3) 7 7 7 7 7 7 7 7 7(3) 7 7 7 7

4 4 4 4 4 4 4 4 4 4 4 4

7 7

7 7

52 13 13 13 13

13 13

52 52 52 52 52 52 52 52 52 52 52 52

Samples with results that are deemed ‘unacceptable’ for Scheme 4A1 will not be assessed in Scheme 4A1i.

UK NEQAS for H&I is operated by Velindre NHS Trust, a UKAS proficiency testing provider No 8351. © Confidential report; no data may be published without permission from UK NEQAS for H&I

Acceptable Unacceptable

Comments

NEQ-137 Issue 1 Effective Date 06/02/17 P. 5 of 5